The Norwegian Radium Hospital, The Research Building
In a recent issue of Journal of Cell Biology, PhD student Liliane Christ at Institute for Cancer Research and Centre for Cancer Biomedicine provides new insight into how daughter cells are separated during the end of cell division. In the same issue, a “Biobytes” podcast with group leader Harald Stenmark and co-corresponding author Coen Campsteijn explains the importance of this work, as does a commentary article by two external experts in the field.
We congratulate CCB co-director Ragnhild A. Lothe from the Department of Molecular Oncology at the Institute for Cancer Research with achieving the substantial NFR TOPPFORSK funding grant for the project “Modeling tumor heterogeneity in colorectal cancer management”.
The ongoing work of CCB's Camilla Raiborg has recently been presented on the Norwegian popular science website forskning.no as well as on the Norwegian Cancer Society web page. Raiborg is heading the project group "Protein dynamics in tumor suppressor pathways" in Harald Stenmark's group at the Department of Molecular Cell Biology, Institute for Cancer Research, OUH.
Before Christmas The Norwegian Cancer Society and the Research Council of Norway distributed 56 million NOK to various innovation projects. Products that cancer patients are in need of will be developed by these projects. TTOs (Technology Transfer Offices) and Inven2 are project leaders for the majority of these projects.
CCB's principal investigator Prof. Kirsten Sandvig recently received a new grant for work with biodegradable nanoparticles through INNO INDIGO which is an innovation-driven initiative for the development and integration of Indian and European research.